Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × zanubrutinib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, B-Cell, Marginal Zone 8 Waldenstrom Macroglobulinemia 7 Lymphoma, Mantle-Cell 7 Lymphoma, Follicular 7 Lymphoma 4 Recurrence 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Neoplasms 2 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 5 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 ibrutinib 2 acalabrutinib 2 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 ricolinostat 1 pirtobrutinib 1 obinutuzumab 1 idelalisib 1 idecabtagene vicleucel 1 Vincristine 1 Stem Cell Transplantation 1 Prednisone 1 Leukapheresis 1 Filgrastim 1 Doxorubicin 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡